BANK OF MONTREAL /CAN/ - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 15 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$694,000
-29.3%
142,846
+36.7%
0.00%
-100.0%
Q1 2021$982,000
+28.5%
104,524
+27.7%
0.00%0.0%
Q4 2020$764,000
+76300.0%
81,882
+26313.5%
0.00%
Q3 2020$1,000
-50.0%
3100.0%0.00%
Q2 2020$2,000
+100.0%
3100.0%0.00%
Q1 2020$1,000
-50.0%
3100.0%0.00%
Q4 2019$2,000
+100.0%
3100.0%0.00%
Q3 2019$1,000
-50.0%
3100.0%0.00%
Q2 2019$2,000
+100.0%
3100.0%0.00%
Q1 2019$1,0003100.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 275,000$1,103,0000.40%
Manatuck Hill Partners, LLC 273,100$1,095,0000.38%
Stonepine Capital Management, LLC 165,775$665,0000.30%
Ikarian Capital, LLC 311,041$1,247,0000.09%
COOPERMAN LEON G 200,000$802,0000.04%
Jump Financial, LLC 18,300$73,0000.01%
Shay Capital LLC 10,000$40,0000.01%
Newbridge Financial Services Group, Inc. 1,510$6,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 30,904$124,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$5,0000.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders